Clinical Trials Browser

Phase 1/2 × Triple Negative Breast Neoplasms × Spironolactone × Clear all

NCT05933265 2025-03-06

Study of LP-184 in Patients With Advanced Solid Tumors

Phase 1/2 Recruiting

Neoplasm Metastasis, Neoplasms, Triple Negative Breast Neoplasms